Literature DB >> 27650433

IGF-1 in retinopathy of prematurity, a CNS neurovascular disease.

Raffael Liegl1, Chatarina Löfqvist2, Ann Hellström2, Lois E H Smith3.   

Abstract

The retina is part of the central nervous system and both the retina as well as the brain can suffer from severe damage after very preterm birth. Retinopathy of prematurity is one of the major causes of blindness in these children and brain neuronal impairments including cognitive defects, cerebral palsy and intraventricular hemorrhage (IVH) are also complications of very preterm birth. Insulin-like growth factor 1 (IGF-1) acts to promote proliferation, maturation, growth and survival of neural cells. Low levels of circulating IGF-1 are associated with ROP and defects in the IGF-1 gene are associated with CNS disorders including learning deficits and brain growth restriction. Treatment of preterm infants with recombinant IGF-1 may potentially prevent ROP and CNS disorders. This review compares the role of IGF-1 in ROP and CNS disorders. A recent phase 2 study showed a positive effect of IGF-1 on the severity of IVH but no effect on ROP. A phase 3 trial is planned.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27650433      PMCID: PMC5085844          DOI: 10.1016/j.earlhumdev.2016.09.008

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  137 in total

1.  Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation.

Authors:  W Tin; D W Milligan; P Pennefather; E Hey
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2001-03       Impact factor: 5.747

Review 2.  The management of retinopathy of prematurity.

Authors:  J D Reynolds
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons.

Authors:  M Yamada; K Tanabe; K Wada; K Shimoke; Y Ishikawa; T Ikeuchi; S Koizumi; H Hatanaka
Journal:  J Neurochem       Date:  2001-09       Impact factor: 5.372

4.  Apoptotic cell death and caspase-3 activation induced by N-methyl-D-aspartate receptor antagonists and their prevention by insulin-like growth factor I.

Authors:  T Takadera; I Matsuda; T Ohyashiki
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

5.  Retinopathy of prematurity, a decrease in frequency and severity. Trends over 16 years in a Danish county.

Authors:  H C Fledelius; H Dahl
Journal:  Acta Ophthalmol Scand       Date:  2000-06

6.  Insulin-like growth factor-I is necessary for neural stem cell proliferation and demonstrates distinct actions of epidermal growth factor and fibroblast growth factor-2.

Authors:  Y Arsenijevic; S Weiss; B Schneider; P Aebischer
Journal:  J Neurosci       Date:  2001-09-15       Impact factor: 6.167

7.  Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion.

Authors:  C Camacho-Hübner; K A Woods; F Miraki-Moud; P C Hindmarsh; A J Clark; Y Hansson; A Johnston; R C Baxter; M O Savage
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

8.  Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development.

Authors:  J R O'Kusky; P Ye; A J D'Ercole
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

9.  Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity.

Authors:  S Yakar; J L Liu; A M Fernandez; Y Wu; A V Schally; J Frystyk; S D Chernausek; W Mejia; D Le Roith
Journal:  Diabetes       Date:  2001-05       Impact factor: 9.461

10.  Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity.

Authors:  A Hellstrom; C Perruzzi; M Ju; E Engstrom; A L Hard; J L Liu; K Albertsson-Wikland; B Carlsson; A Niklasson; L Sjodell; D LeRoith; D R Senger; L E Smith
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-01       Impact factor: 11.205

View more
  8 in total

1.  Systemic Inflammation-Associated Proteins and Retinopathy of Prematurity in Infants Born Before the 28th Week of Gestation.

Authors:  Mari Holm; Tora S Morken; Raina N Fichorova; Deborah K VanderVeen; Elizabeth N Allred; Olaf Dammann; Alan Leviton
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-12-01       Impact factor: 4.799

2.  Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity.

Authors:  Lynn Calvin Shaw; Sergio Li Calzi; Nan Li; Leni Moldovan; Nilanjana Sengupta-Caballero; Judith Lindsey Quigley; Mircea Ivan; Bokkyoo Jun; Nicolas G Bazan; Michael Edwin Boulton; Julia Busik; Josef Neu; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-02-01       Impact factor: 4.799

3.  RELATIONSHIP BETWEEN INSULIN-LIKE GROWTH FACTOR TYPE 1 AND INTRAUTERINE GROWTH.

Authors:  Lidija Banjac; Jelena Kotur-Stevuljević; Tamara Gojković; Vesna Bokan-Mirković; Goran Banjac; Gorica Banjac
Journal:  Acta Clin Croat       Date:  2020-03       Impact factor: 0.780

Review 4.  Harnessing retinal phagocytes to combat pathological neovascularization in ischemic retinopathies?

Authors:  Anne Klotzsche-von Ameln; David Sprott
Journal:  Pflugers Arch       Date:  2022-05-07       Impact factor: 4.458

5.  Insulin-like growth factor 1 receptor mediates photoreceptor neuroprotection.

Authors:  Ammaji Rajala; Kenneth Teel; Mohd A Bhat; Albert Batushansky; Timothy M Griffin; Lindsey Purcell; Raju V S Rajala
Journal:  Cell Death Dis       Date:  2022-07-15       Impact factor: 9.685

6.  Clinical outcome and gut development after insulin-like growth factor-1 supplementation to preterm pigs.

Authors:  Kristine Holgersen; Martin Bo Rasmussen; Galen Carey; Douglas G Burrin; Thomas Thymann; Per Torp Sangild
Journal:  Front Pediatr       Date:  2022-08-05       Impact factor: 3.569

Review 7.  Concurrent Physiological and Pathological Angiogenesis in Retinopathy of Prematurity and Emerging Therapies.

Authors:  Chang Dai; Keith A Webster; Amit Bhatt; Hong Tian; Guanfang Su; Wei Li
Journal:  Int J Mol Sci       Date:  2021-05-01       Impact factor: 5.923

8.  Is there evidence that the yearly numbers of children newly certified with sight impairment in England and Wales has increased between 1999/2000 and 2014/2015? A cross-sectional study.

Authors:  Catey Bunce; Antra Zekite; Richard Wormald; Richard Bowman
Journal:  BMJ Open       Date:  2017-09-01       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.